Home  »  Website  »  National  »  There Should Be An Increase In Gap Between Two Doses Of Covishield: Govt Panel

There Should Be An Increase In Gap Between Two Doses Of Covishield: Govt Panel

The NTAGI has stated that those having laboratory tests proven SARS-CoV-2 illness should defer Covid-19 vaccination for six months after recovery, the sources said.

13 May 2021, Last Updated at 11:55 am
Follow Outlook India On News
The recommendations of the NTAGI will be sent to the National Expert Group on Vaccine Administration for Covid-19.
File photo
There Should Be An Increase In Gap Between Two Doses Of Covishield: Govt Panel
outlookindia.com
2021-05-13T11:55:36+05:30
Also read

The gap between two doses of Covishield vaccines should be increased to 12-16 weeks, the National Technical Advisory Group on Immunisation (NTAGI) recommended on Thursday. Currently, the interval between two doses of Covishield is four to eight weeks.

It has also suggested that pregnant women may be offered the choice to take any Covid-19 vaccine and that lactating women can be inoculated any time after delivery.

The NTAGI has also stated that those having laboratory tests proven SARS-CoV-2 illness should defer Covid-19 vaccination for six months after recovery, the sources said.

No change in dosage interval for Covaxin has been suggested by the panel.

The recommendations of the NTAGI will be sent to the National Expert Group on Vaccine Administration for Covid-19.

With PTI inputs

 


For in-depth, objective and more importantly balanced journalism, Click here to subscribe to Outlook Magazine

Subscribe to Outlook’s Newsletter

Next Story >>

Covaxin Receives Nod For Trials On Children Between 2-18 Age Group

Read More in:

Outlook Web Bureau Delhi Covishield COVID-19 Coronavirus COVID-19 Vaccine National

More from India

More From Outlook Magazine

More from Website

More from Blog